Stay updated on SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial

Sign up to get notified when there's something new on the SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Added a Locations section with Maryland and Texas sites and UT Southwestern Medical Center as sponsor, and updated the revision to v3.3.3. The update also removes the HHS Vulnerability Disclosure link and the prior Maryland, Texas, and UT Southwestern Medical Center entries (v3.3.2).
    Difference
    0.4%
    Check dated 2025-12-23T22:19:27.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    44 days ago
    Change Detected
    Summary
    A new revision note, v3.3.2, was added and the older v3.2.0 revision was removed. There are no changes to the study content or user-facing information.
    Difference
    0.1%
    Check dated 2025-11-25T11:21:33.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Notice about government funding status (an ancillary alert) was removed from the page, which does not affect the study details or how to use the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:10:55.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The new screenshots show cosmetic formatting updates without changes to study content, eligibility criteria, endpoints, or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T21:06:44.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Updated operating-status notice and version 3.2.0; removed version 3.1.0.
    Difference
    3%
    Check dated 2025-10-06T05:34:51.000Z thumbnail image
  9. Check
    102 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.
    Difference
    0.1%
    Check dated 2025-09-29T03:05:30.000Z thumbnail image

Stay in the know with updates to SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial page.